Tatjana Pandzic

Somatic RUNX1 exonic deletions in myelodysplastic syndrome: A rare yet high-risk recurrent genetic aberration

Al-Djaber, Ahmed; Österroos, Albin; Baldi, Alessandro; Munters, Arielle R. et al.

Ingår i HemaSphere, 2026

• DOI för Somatic RUNX1 exonic deletions in myelodysplastic syndrome: A rare yet high-risk recurrent genetic aberration
• Ladda ner fulltext (pdf) av Somatic RUNX1 exonic deletions in myelodysplastic syndrome: A rare yet high-risk recurrent genetic aberration

Oral mucosal manifestations with identical mutations to the bone marrow in a patient with VEXAS syndrome

Vasaitis, Lilian; Blomstrand, Lena; Pandzic, Tatjana; Gulyas, Miklos et al.

Ingår i Rheumatology & Autoimmunity, s. 60-62, 2026

• DOI för Oral mucosal manifestations with identical mutations to the bone marrow in a patient with VEXAS syndrome
• Ladda ner fulltext (pdf) av Oral mucosal manifestations with identical mutations to the bone marrow in a patient with VEXAS syndrome

A novel PML germline variant as a candidate predisposing genetic aberration in familial acute myeloid leukaemia.

Soussi, Thierry; Kundu, Snehangshu; Gerbaud, Pauline; Pandzic, Tatjana et al.

Ingår i British Journal of Haematology, s. 1118-1121, 2025

• DOI för A novel PML germline variant as a candidate predisposing genetic aberration in familial acute myeloid leukaemia.
• Ladda ner fulltext (pdf) av A novel PML germline variant as a candidate predisposing genetic aberration in familial acute myeloid leukaemia.

Low Rate of Germline Investigation for Variants of Suspected Germline Origin Detected During the Diagnostic Work-Up of Myeloid Neoplasms

Al-Djaber, Ahmed; Munters, Arielle; Cammenga, Jörg; Pandzic, Tatjana et al.

Ingår i eJHaem, 2025

• DOI för Low Rate of Germline Investigation for Variants of Suspected Germline Origin Detected During the Diagnostic Work-Up of Myeloid Neoplasms
• Ladda ner fulltext (pdf) av Low Rate of Germline Investigation for Variants of Suspected Germline Origin Detected During the Diagnostic Work-Up of Myeloid Neoplasms

MALNC: a new mutant NPM1/IDH2^R140 and PML-RARA-associated lncRNA with impact on AML cell proliferation, maturation and drug response

Cozzi, Elisabetta; Neddermeyer, Anne; Zhong, Xiangfu; Gamboa-Cedeño, Angelica María et al.

Ingår i Cancer Gene Therapy, s. 1191-1205, 2025

• DOI för MALNC: a new mutant NPM1/IDH2^R140 and PML-RARA-associated lncRNA with impact on AML cell proliferation, maturation and drug response
• Ladda ner fulltext (pdf) av MALNC: a new mutant NPM1/IDH2^R140 and PML-RARA-associated lncRNA with impact on AML cell proliferation, maturation and drug response

Somatic RUNX1 exonic deletions in myelodysplastic syndrome: A rare yet high-risk recurrent genetic aberration

Al-Djaber, Ahmed; Österroos, Albin; Baldi, Alessandro; Munters, Arielle R. et al.

Ingår i HemaSphere, 2026

• DOI för Somatic RUNX1 exonic deletions in myelodysplastic syndrome: A rare yet high-risk recurrent genetic aberration
• Ladda ner fulltext (pdf) av Somatic RUNX1 exonic deletions in myelodysplastic syndrome: A rare yet high-risk recurrent genetic aberration

Oral mucosal manifestations with identical mutations to the bone marrow in a patient with VEXAS syndrome

Vasaitis, Lilian; Blomstrand, Lena; Pandzic, Tatjana; Gulyas, Miklos et al.

Ingår i Rheumatology & Autoimmunity, s. 60-62, 2026

• DOI för Oral mucosal manifestations with identical mutations to the bone marrow in a patient with VEXAS syndrome
• Ladda ner fulltext (pdf) av Oral mucosal manifestations with identical mutations to the bone marrow in a patient with VEXAS syndrome

A novel PML germline variant as a candidate predisposing genetic aberration in familial acute myeloid leukaemia.

Soussi, Thierry; Kundu, Snehangshu; Gerbaud, Pauline; Pandzic, Tatjana et al.

Ingår i British Journal of Haematology, s. 1118-1121, 2025

• DOI för A novel PML germline variant as a candidate predisposing genetic aberration in familial acute myeloid leukaemia.
• Ladda ner fulltext (pdf) av A novel PML germline variant as a candidate predisposing genetic aberration in familial acute myeloid leukaemia.

Low Rate of Germline Investigation for Variants of Suspected Germline Origin Detected During the Diagnostic Work-Up of Myeloid Neoplasms

Al-Djaber, Ahmed; Munters, Arielle; Cammenga, Jörg; Pandzic, Tatjana et al.

Ingår i eJHaem, 2025

• DOI för Low Rate of Germline Investigation for Variants of Suspected Germline Origin Detected During the Diagnostic Work-Up of Myeloid Neoplasms
• Ladda ner fulltext (pdf) av Low Rate of Germline Investigation for Variants of Suspected Germline Origin Detected During the Diagnostic Work-Up of Myeloid Neoplasms

MALNC: a new mutant NPM1/IDH2^R140 and PML-RARA-associated lncRNA with impact on AML cell proliferation, maturation and drug response

Cozzi, Elisabetta; Neddermeyer, Anne; Zhong, Xiangfu; Gamboa-Cedeño, Angelica María et al.

Ingår i Cancer Gene Therapy, s. 1191-1205, 2025

• DOI för MALNC: a new mutant NPM1/IDH2^R140 and PML-RARA-associated lncRNA with impact on AML cell proliferation, maturation and drug response
• Ladda ner fulltext (pdf) av MALNC: a new mutant NPM1/IDH2^R140 and PML-RARA-associated lncRNA with impact on AML cell proliferation, maturation and drug response

Validation of Guidelines for Genetic Investigation of Myeloid Neoplasms with Germline Predisposition: Results from a Prospective Cohort Study

Tesi, Bianca; Robelius, Anna; Baskin, Berivan; Lazarevic, Vladimir et al.

Ingår i Clinical Cancer Research, s. 3062-3071, 2025

• DOI för Validation of Guidelines for Genetic Investigation of Myeloid Neoplasms with Germline Predisposition: Results from a Prospective Cohort Study
• Ladda ner fulltext (pdf) av Validation of Guidelines for Genetic Investigation of Myeloid Neoplasms with Germline Predisposition: Results from a Prospective Cohort Study

Pathogenic DDX41 variants, possible response predictors to low-dose melphalan in hypo- and normocellular MDS and AML

Nyquist, Otto Emil; Dalgaard, Jakob; Spetalen, Signe; Torkildsen, Synne et al.

Ingår i British Journal of Haematology, s. 724-729, 2024

• DOI för Pathogenic DDX41 variants, possible response predictors to low-dose melphalan in hypo- and normocellular MDS and AML

Precision Diagnostics in Myeloid Malignancies: Development and Validation of a National Capture‐Based Gene Panel

Orsmark‐Pietras, Christina; Lyander, Anna; Ladenvall, Claes; Hallström, Björn et al.

Ingår i Genes, Chromosomes and Cancer, 2024

• DOI för Precision Diagnostics in Myeloid Malignancies: Development and Validation of a National Capture‐Based Gene Panel
• Ladda ner fulltext (pdf) av Precision Diagnostics in Myeloid Malignancies: Development and Validation of a National Capture‐Based Gene Panel

Cancer associated variant enrichment CAVE, a gene agnostic approach to identify low burden variants in chronic lymphocytic leukemia

Yaacov, Adar; Lazarian, Gregory; Pandzic, Tatjana; Weström, Simone et al.

Ingår i Scientific Reports, 2024

• DOI för Cancer associated variant enrichment CAVE, a gene agnostic approach to identify low burden variants in chronic lymphocytic leukemia
• Ladda ner fulltext (pdf) av Cancer associated variant enrichment CAVE, a gene agnostic approach to identify low burden variants in chronic lymphocytic leukemia

Micro-costing of genetic diagnostics in acute leukemia in Sweden: from standard-of-care to whole-genome sequencing

Thangavelu, Tharshini; Wirta, Valtteri; Orsmark-Pietras, Christina; Cavelier, Lucia et al.

Ingår i Journal of Medical Economics, s. 1053-1060, 2024

• DOI för Micro-costing of genetic diagnostics in acute leukemia in Sweden: from standard-of-care to whole-genome sequencing
• Ladda ner fulltext (pdf) av Micro-costing of genetic diagnostics in acute leukemia in Sweden: from standard-of-care to whole-genome sequencing

Patient-Specific Measurable Residual Disease Markers Predict Outcome in Patients With Myelodysplastic Syndrome and Related Diseases After Hematopoietic Stem-Cell Transplantation

Tobiasson, Magnus; Pandzic, Tatjana; Illman, Johanna; Nilsson, Lars et al.

Ingår i Journal of Clinical Oncology, 2024

• DOI för Patient-Specific Measurable Residual Disease Markers Predict Outcome in Patients With Myelodysplastic Syndrome and Related Diseases After Hematopoietic Stem-Cell Transplantation

BTK and PLCG2 remain unmutated in one-third of patients with CLL relapsing on ibrutinib

Bonfiglio, Silvia; Sutton, Lesley-Ann; Ljungström, Viktor; Capasso, Antonella et al.

Ingår i Blood Advances, s. 2794-2806, 2023

• DOI för BTK and PLCG2 remain unmutated in one-third of patients with CLL relapsing on ibrutinib
• Ladda ner fulltext (pdf) av BTK and PLCG2 remain unmutated in one-third of patients with CLL relapsing on ibrutinib

Ultra-sensitive monitoring of leukemia patients using superRCA mutation detection assays

Chen, Lei; Eriksson, Anna; Weström, Simone; Pandzic, Tatjana et al.

Ingår i Nature Communications, 2022

• DOI för Ultra-sensitive monitoring of leukemia patients using superRCA mutation detection assays
• Ladda ner fulltext (pdf) av Ultra-sensitive monitoring of leukemia patients using superRCA mutation detection assays

Loss of Y and clonal hematopoiesis in blood: two sides of the same coin?

Ljungström, Viktor; Mattisson, Jonas; Halvardson, Jonatan; Pandzic, Tatjana et al.

Ingår i Leukemia, s. 889-891, 2022

• DOI för Loss of Y and clonal hematopoiesis in blood: two sides of the same coin?
• Ladda ner fulltext (pdf) av Loss of Y and clonal hematopoiesis in blood: two sides of the same coin?

Clonal haematopoiesis as a risk factor for therapy-related myeloid neoplasms in patients with chronic lymphocytic leukaemia treated with chemo-(immuno)therapy

Voso, Maria-Teresa; Pandzic, Tatjana; Falconi, Giulia; Dencic-Fekete, Marija et al.

Ingår i British Journal of Haematology, s. 103-113, 2022

• DOI för Clonal haematopoiesis as a risk factor for therapy-related myeloid neoplasms in patients with chronic lymphocytic leukaemia treated with chemo-(immuno)therapy

Familial platelet disorder due to germline exonic deletions in RUNX1: a diagnostic challenge with distinct alterations of the transcript isoform equilibrium

Engvall, Marie; Karlsson, Ylva; Kuchinskaya, Ekaterina; Jörnegren, Åsa et al.

Ingår i Leukemia and Lymphoma, s. 2311-2320, 2022

• DOI för Familial platelet disorder due to germline exonic deletions in RUNX1: a diagnostic challenge with distinct alterations of the transcript isoform equilibrium
• Ladda ner fulltext (pdf) av Familial platelet disorder due to germline exonic deletions in RUNX1: a diagnostic challenge with distinct alterations of the transcript isoform equilibrium

Five Percent Variant Allele Frequency Is a Reliable Reporting Threshold for TP53 Variants Detected by Next Generation Sequencing in Chronic Lymphocytic Leukemia in the Clinical Setting

Pandzic, Tatjana; Ladenvall, Claes; Engvall, Marie; Mattsson, Mattias et al.

Ingår i HemaSphere, 2022

• DOI för Five Percent Variant Allele Frequency Is a Reliable Reporting Threshold for TP53 Variants Detected by Next Generation Sequencing in Chronic Lymphocytic Leukemia in the Clinical Setting
• Ladda ner fulltext (pdf) av Five Percent Variant Allele Frequency Is a Reliable Reporting Threshold for TP53 Variants Detected by Next Generation Sequencing in Chronic Lymphocytic Leukemia in the Clinical Setting

Comparative analysis of targeted next-generation sequencing panels for the detection of gene mutations in chronic lymphocytic leukemia: an ERIC multi-center study

Sutton, Lesley-Ann; Ljungström, Viktor; Enjuanes, Anna; Cortese, Diego et al.

Ingår i Haematologica, s. 682-691, 2021

• DOI för Comparative analysis of targeted next-generation sequencing panels for the detection of gene mutations in chronic lymphocytic leukemia: an ERIC multi-center study
• Ladda ner fulltext (pdf) av Comparative analysis of targeted next-generation sequencing panels for the detection of gene mutations in chronic lymphocytic leukemia: an ERIC multi-center study

Cell-of-origin determined by both gene expression profiling and immunohistochemistry is the strongest predictor of survival in patients with diffuse large B-cell lymphoma

Abdulla, Maysaa; Hollander, Peter; Pandzic, Tatjana; Mansouri, Larry et al.

Ingår i American Journal of Hematology, s. 57-67, 2020

• DOI för Cell-of-origin determined by both gene expression profiling and immunohistochemistry is the strongest predictor of survival in patients with diffuse large B-cell lymphoma
• Ladda ner fulltext (pdf) av Cell-of-origin determined by both gene expression profiling and immunohistochemistry is the strongest predictor of survival in patients with diffuse large B-cell lymphoma

Clonal hematopoiesis in patients with high-grade B-cell lymphoma is associated with inferior outcome

Amini, Rose-Marie; Ljungström, Viktor; Abdulla, Maysaa; Cavelier, Lucia et al.

Ingår i American Journal of Hematology, 2020

• DOI för Clonal hematopoiesis in patients with high-grade B-cell lymphoma is associated with inferior outcome
• Ladda ner fulltext (pdf) av Clonal hematopoiesis in patients with high-grade B-cell lymphoma is associated with inferior outcome

Restoration of KMT2C/MLL3 in human colorectal cancer cells reinforces genome-wide H3K4me1 profiles and influences cell growth and gene expression

Larsson, Chatarina; Cordeddu, Lina; Siggens, Lee; Djureinovic, Tatjana et al.

Ingår i Clinical Epigenetics, 2020

• DOI för Restoration of KMT2C/MLL3 in human colorectal cancer cells reinforces genome-wide H3K4me1 profiles and influences cell growth and gene expression
• Ladda ner fulltext (pdf) av Restoration of KMT2C/MLL3 in human colorectal cancer cells reinforces genome-wide H3K4me1 profiles and influences cell growth and gene expression

Angioimmunoblastic T-cell lymphoma and myelodysplastic syndrome with mutations in TET2, DNMT3 and CUX1: azacitidine induces only lymphoma remission

Tobiasson, Magnus; Pandzic, Tatjana; Cavelier, Lucia; Sander, Birgitta et al.

Ingår i Leukemia and Lymphoma, s. 3316-3319, 2019

• DOI för Angioimmunoblastic T-cell lymphoma and myelodysplastic syndrome with mutations in TET2, DNMT3 and CUX1: azacitidine induces only lymphoma remission

Highly similar genomic landscapes in monoclonal B-cell lymphocytosis and ultra-stable chronic lymphocytic leukemia with low frequency of driver mutations

Agathangelidis, Andreas; Ljungström, Viktor; Scarfo, Lydia; Fazi, Claudia et al.

Ingår i Haematologica, s. 865-873, 2018

• DOI för Highly similar genomic landscapes in monoclonal B-cell lymphocytosis and ultra-stable chronic lymphocytic leukemia with low frequency of driver mutations
• Ladda ner fulltext (pdf) av Highly similar genomic landscapes in monoclonal B-cell lymphocytosis and ultra-stable chronic lymphocytic leukemia with low frequency of driver mutations

Loss of DIP2C in RKO cells stimulates changes in DNA methylation and epithelial-mesenchymal transition

Larsson, Chatarina; Ali, Muhammad Akhtar; Djureinovic, Tatjana; Lindroth, Anders M. et al.

Ingår i BMC Cancer, 2017

• DOI för Loss of DIP2C in RKO cells stimulates changes in DNA methylation and epithelial-mesenchymal transition
• Ladda ner fulltext (pdf) av Loss of DIP2C in RKO cells stimulates changes in DNA methylation and epithelial-mesenchymal transition

Somatic PRDM2 c.4467delA mutations in colorectal cancers control histone methylation and tumor growth

Pandzic, Tatjana; Rendo, Verónica; Lim, Jinyeong; Larsson, Chatarina et al.

Ingår i Oncotarget, s. 98646-98659, 2017

• DOI för Somatic PRDM2 c.4467delA mutations in colorectal cancers control histone methylation and tumor growth

Mechanistic characterization of a copper containing thiosemicarbazone with potent antitumor activity

Karlsson, Henning; Fryknäs, Mårten; Strese, Sara; Gullbo, Joachim et al.

Ingår i Oncotarget, s. 30217-30234, 2017

• DOI för Mechanistic characterization of a copper containing thiosemicarbazone with potent antitumor activity
• Ladda ner fulltext (pdf) av Mechanistic characterization of a copper containing thiosemicarbazone with potent antitumor activity

Frequent NFKBIE deletions are associated with poor outcome in primary mediastinal B-cell lymphoma

Mansouri, Larry; Noerenberg, Daniel; Young, Emma; Mylonas, Elena et al.

Ingår i Blood, s. 2666-2670, 2016

• DOI för Frequent NFKBIE deletions are associated with poor outcome in primary mediastinal B-cell lymphoma

Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutations

Ljungström, Viktor; Cortese, Diego; Young, Emma; Pandzic, Tatjana et al.

Ingår i Blood, s. 1007-1016, 2016

• DOI för Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutations

Transposon Mutagenesis Reveals Fludarabine Resistance Mechanisms in Chronic Lymphocytic Leukemia

Pandzic, Tatjana; Larsson, Jimmy; He, Liqun; Kundu, Snehangshu et al.

Ingår i Clinical Cancer Research, s. 6217-6227, 2016

• DOI för Transposon Mutagenesis Reveals Fludarabine Resistance Mechanisms in Chronic Lymphocytic Leukemia

DISSECTING RESISTANCE MECHANISMS IN CHRONIC LYMPHOCYTIC LEUKEMIA USING WHOLE-EXOME SEQUENCING: IMPACT OF RECURRENT RPS15 MUTATIONS ON P53 DYSREGULATION

Ljungström, Viktor; Cortese, Diego; Young, Emma; Pandzic, Tatjana et al.

Ingår i Haematologica, s. 10-11, 2015

Computational and molecular tools for scalable rAAV-mediated genome editing

Stoimenov, Ivaylo; Ali, Muhammad Akhtar; Pandzic, Tatjana; Sjöblom, Tobias

Ingår i Nucleic Acids Research, 2015

• DOI för Computational and molecular tools for scalable rAAV-mediated genome editing

MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP pool

Gad, Helge; Koolmeister, Tobias; Jemth, Ann-Sofie; Eshtad, Saeed et al.

Ingår i Nature, s. 215-221, 2014

• DOI för MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP pool

Gene rearrangements in hormone receptor negative breast cancers revealed by mate pair sequencing

Jiao, Xiang; Hooper, Sean D.; Djureinovic, Tatjana; Larsson, Chatarina et al.

Ingår i BMC Genomics, 2013

• DOI för Gene rearrangements in hormone receptor negative breast cancers revealed by mate pair sequencing
• Ladda ner fulltext (pdf) av Gene rearrangements in hormone receptor negative breast cancers revealed by mate pair sequencing

N-Acyl Taurines are Anti-Proliferative in Prostate Cancer Cells

Chatzakos, Vicky; Slatis, Katharina; Djureinovic, Tatjana; Helleday, Thomas et al.

Ingår i Lipids, s. 355-361, 2012

• DOI för N-Acyl Taurines are Anti-Proliferative in Prostate Cancer Cells

Clonal evolution patterns in high-risk chronic lymphocytic leukemia treated with ibrutinib

Mattsson, Mattias; Ljungström, Viktor; Djureinovic, Tatjana; Mansouri, Larry et al.